Research has demonstrated that PI3Ks and their downstream effectors, such as AKT and the mammalian target of rapamycin (mTOR), are critical regulators of glycolysis, cancer metabolism, and cancer cell proliferation28. This evidence concerns the gene AKT1 and cancer.